Sanofi | SNY - Equity Capital And Reserves

Stock Price
46.15
Daily Change
-1.39 -2.92%
Monthly
0.26%
Yearly
-11.83%
Q2 Forecast
45.74

Sanofi reported EUR71.71B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Amgen USD 8.66B 961M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 758.17M 22.16M Dec/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Galapagos EUR 3.24B 788.91M Dec/2025
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Glaxosmithkline GBP 22.06B 360M Dec/2025
J&J USD 81.19B 358M Mar/2026
Merck USD 51.85B 2.79B Sep/2025
Novartis USD 46.13B 1.38B Dec/2025
Novartis USD 46.13B 1.8B Dec/2025
Pacira USD 693.11M 34.1M Dec/2025
Perrigo USD 2.94B 1.51B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
Sanofi EUR 71.71B 14.25B Dec/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
UCB EUR 10.87B 1.18B Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025